BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17172593)

  • 1. Heredity and DNA methylation in colorectal cancer.
    Jass JR
    Gut; 2007 Jan; 56(1):154-5. PubMed ID: 17172593
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA methylation in breast and colorectal cancers.
    Samowitz WS; Ogino S
    Mod Pathol; 2008 Aug; 21(8):1054; author reply 1054-5. PubMed ID: 18654590
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
    Deng G; Chen A; Hong J; Chae HS; Kim YS
    Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying hereditary nonpolyposis colorectal cancer.
    Lynch HT; Smyrk TC
    N Engl J Med; 1998 May; 338(21):1537-8. PubMed ID: 9593794
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of early-onset "sporadic" colorectal cancer with microsatellite instability.
    Jass JR
    Dis Colon Rectum; 2003 Oct; 46(10):1305-9. PubMed ID: 14530666
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics of hereditary nonpolyposis colorectal cancer.
    Akrami SM
    Arch Iran Med; 2006 Oct; 9(4):381-9. PubMed ID: 17061614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Wullen B; Mühlhöfer A; Zoller WG
    Z Gastroenterol; 2001 Nov; 39(11):981-4. PubMed ID: 11778159
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methylation is a frequent mechanism of inactivation of the hMLH1 gene copies in sporadic colonic cancer].
    Larsen CJ
    Bull Cancer; 1998 Sep; 85(9):741-2. PubMed ID: 9817055
    [No Abstract]   [Full Text] [Related]  

  • 10. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes.
    Woods MO; Hyde AJ; Curtis FK; Stuckless S; Green JS; Pollett AF; Robb JD; Green RC; Croitoru ME; Careen A; Chaulk JA; Jegathesan J; McLaughlin JR; Gallinger SS; Younghusband HB; Bapat BV; Parfrey PS
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6853-61. PubMed ID: 16203774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor.
    Gazzoli I; Loda M; Garber J; Syngal S; Kolodner RD
    Cancer Res; 2002 Jul; 62(14):3925-8. PubMed ID: 12124320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between familial and sporadic forms of colorectal cancer with DNA microsatellite instability.
    Dionigi G; Bianchi V; Villa F; Rovera F; Boni L; Annoni M; Castano P; Dionigi R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S37-42. PubMed ID: 18023569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors.
    Seruca R; Velho S; Oliveira C; Leite M; Matos P; Jordan P
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):5-9. PubMed ID: 19210107
    [No Abstract]   [Full Text] [Related]  

  • 15. Decoding hereditary colorectal cancer.
    Boland CR
    N Engl J Med; 2006 Jun; 354(26):2815-7. PubMed ID: 16807419
    [No Abstract]   [Full Text] [Related]  

  • 16. Inherited epimutation or a haplotypic basis for the propensity to silence?
    Suter CM; Martin DI
    Nat Genet; 2007 May; 39(5):573; author reply 576. PubMed ID: 17460681
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene symbol: MLH1. Disease: Hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
    Hum Genet; 2005 May; 116(6):535. PubMed ID: 15991306
    [No Abstract]   [Full Text] [Related]  

  • 18. Two novel germline mutations (Y548X and K732X) of the MLH1 gene in Czech patients with hereditary nonpolyposis colorectal cancer.
    Hajer J; Kepelová A; Zádorová Z; Kment M
    Hum Mutat; 2000 Aug; 16(2):181. PubMed ID: 10923051
    [No Abstract]   [Full Text] [Related]  

  • 19. HMLH1 and HMSH2 germline mutations in Greek families with hereditary non-polyposis colorectal cancer.
    Kataki A; Gomatos IP; Arapis K; Mparatsis S; Alepas P; Kaintatzis A; Nikolopoulou M; Leandros E; Konstadoulakis MM; Bramis J
    Clin Genet; 2006 Mar; 69(3):290-3. PubMed ID: 16542397
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.